We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
4 own
3 watching
Current Price
$24
$1.43
(6.34%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
1,450.64M
52-Week High
43
52-Week Low
10.7
Average Volume
0.87M
Dividend Yield
--
P/E Ratio
--
Market Capitalization1,450.64M
52-Week High43
52-Week Low10.7
Average Volume0.87M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
PR Newswire
11days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verve Therapeutics, Inc. - VERV PR Newswire NEW YORK, Nov. 21, 2022 NEW YORK, Nov. 21, 2022...
Zolmax
22days ago
Verve Therapeutics, Inc. (NASDAQ:VERV Get Rating) major shareholder 2017 Gp L.L.C. Gv sold 97,166 shares of the businesss stock in a transaction dated Friday, November 4th. The shares were sold at an average price of $31.14, for a total transaction of $3,025,749.24. The transaction ...
Globe Newswire
22days ago
BOSTON, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Sekar Kathiresan, M.D., co-founder and chief executive officer, will ...
Ticker Report
26days ago
Verve Therapeutics, Inc. (NASDAQ:VERV Get Rating) major shareholder 2017 Gp L.L.C. Gv sold 57,303 shares of the stock in a transaction dated Wednesday, November 2nd. The stock was sold at an average price of $35.94, for a total transaction of $2,059,469.82. The sale was disclosed in a ...
TheStreet.com - Investing
2 months ago
In drug development, cash is king, especially during a market correction.In drug development, cash is king, especially during a market correction.If you think tech stocks have it rough right now, sneak a peek at biotech stocks. The sector is in the midst of its most severe correction ever. ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$24
$1.43
(6.34%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00